학술논문

Assessment of the CYP3A4 Induction Potential by Carbamazepine: Insights from Two Clinical DDI Studies and PBPK Modeling.
Document Type
Article
Source
Clinical Pharmacology & Therapeutics; May2024, Vol. 115 Issue 5, p1025-1032, 8p
Subject
CARBAMAZEPINE
CYTOCHROME P-450 CYP3A
DRUG interactions
CLINICAL pharmacology
DRUG development
SCIENTIFIC community
Language
ISSN
00099236
Abstract
Copyright of Clinical Pharmacology & Therapeutics is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)